Compass Therapeutics

Over the weekend was International Women’s Day and today we want to share our appreciate for the incredible women advancing innovation in science! From the lab to the clinic, their leadership, skill, and dedication help drive our mission to develop new therapies for people living with cancer. #InternationalWomensDay #WomenInScience #WomenInBiotech

Join us in welcoming Craig Bodycombe to Compass as Director of Analytical Development. Craig brings 20 years of progressive experience in the biotechnology and pharmaceutical industries, specializing in protein therapeutics, including more than 10 years working with monoclonal antibodies. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Cholangiocarcinoma (CCA) Awareness Month reminds us of the progress made—and the work that remains. CCA is an aggressive cancer with significant unmet need—especially for patients facing advanced disease. At Compass Therapeutics, we’re focused on translating science into meaningful progress for patients, including those facing hard-to-treat cancers. We are proud to stand with the Cholangiocarcinoma Foundation, honoring the entire CCA community—patients, caregivers, clinicians, researchers, and advocates—who keep moving forward, together. To learn more, visit: ow.ly/C7lb50Y7V2J #Cholangiocarcinoma #CCAMonth #CureCCA #CCAHope #CancerAwareness #Oncology #Biotech #Research

Please welcome Varsha Menon to the Compass team as our Director of Biometrics! Varsha brings deep experience as a Biometrics Lead, Oncology TA partner, and in patient advocacy. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Join us at the 44th Annual J.P. Morgan Healthcare Conference for a live presentation and webcast with Thomas Schuetz, MD, PhD, CEO of Compass Therapeutics. Location: San Francisco Date: Wednesday, January 14, 2026 Time: 7:30–8:10 a.m. PT Register now to watch live or on demand at cmpx.info/jpmorgan. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Compass Therapeutics announces the appointments of Arjun Prasad, MBA, MPH, as Chief Commercial Officer, and Cynthia Sirard, MD, as Chief Medical Officer. “We are thrilled to welcome Arjun and Cyndi to the Compass team. They are highly accomplished leaders with decades of commercial and clinical development experience,” said Thomas Schuetz, MD, PhD, Compass CEO and Board Vice Chairman. Read the news release at cmpx.info/appointments. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Join us at the 44th Annual J.P. Morgan Healthcare Conference for a live presentation and webcast with Thomas Schuetz, MD, PhD, CEO of Compass Therapeutics. Location: San Francisco Date: Wednesday, January 14, 2026 Time: 7:30–8:10 a.m. PT Register now to watch live or on demand at cmpx.info/jpmorgan. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Don’t miss tomorrow’s live presentation and webcast from Compass Therapeutics CEO Thomas Schuetz, MD, PhD, at the 8th Annual Evercore Healthcare Conference. Location: Coral Gables, FL Date: Thursday, Dec. 4, 2025 Time: 10:00 a.m. ET Register now to view the live webcast: cmpx.info/evercore. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Tomorrow — Join Compass Therapeutics CEO Thomas Schuetz, MD, PhD, for a live presentation and webcast at the Piper Sandler 37th Annual Healthcare Conference. Location: New York City Date: Tuesday, Dec. 2 Time: 8 a.m. ET Register now to view the live webcast: cmpx.info/piper. #CMPX #biopharmaceutical #therapeutics #immunotherapy

Today — Join Compass Therapeutics CEO Thomas Schuetz, MD, PhD, for a presentation at the Jefferies Global Healthcare Conference in London. When: • Today - Thurs., Nov. 20 • 12:30 p.m. GMT Register now to view the live webcast: cmpx.info/jefferies #CMPX #biopharmaceutical #therapeutics #immunotherapy #JefferiesHealthcare

Today! Watch Thomas Schuetz, MD, PhD, and CEO, Compass Therapeutics, present at the Stifel 2025 Healthcare Conference in New York City. When: • Today - Wed., Nov. 12 • 4 p.m. ET Register now to view the live webcast: cmpx.info/stifel #CMPX #biopharmaceutical #therapeutics #immunotherapy

Today! Join Compass Therapeutics CEO Thomas Schuetz, MD, PhD, for a presentation at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston. When: • Today - Monday, Nov. 10 • 3:30 p.m. ET Register now to view the live webcast: cmpx.info/guggenheim #CMPX #biopharmaceutical #therapeutics #immunotherapy

Join us as we present preclinical data on CTX-10726, a differentiated PD-1 x VEGF-A bispecific antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting. Presentation Details: * Title: Preclinical Development of CTX-10726, a Tetravalent Bispecific Antibody Targeting PD-1 and VEGF-A for the Treatment of Patients with Cancer * Date/Time: Nov. 7, at 12:15 pm and 5:35 pm * Abstract number: 1151 * Presenter: Diana Albu, PhD, Associate Director * Location: Exhibit Halls AB Read the news release at ow.ly/7KE450XmssB. #SITC25 #CMPX #biotech #biopharmaceutical #therapeutics #immunotherapy

Join us as we participate in these investor events during November: * Guggenheim 2nd Annual Healthcare Innovation Conference Boston, Mass. Monday, Nov. 10 at 3:30 pm ET Webcast: ow.ly/ZyPb50XkCuI * Stifel 2025 Healthcare Conference New York, N.Y. Wednesday, Nov. 12 at 4:00 pm ET Webcast: ow.ly/wOC250XkCuG * Jefferies Global Healthcare Conference London, U.K. Thursday, Nov. 20 at 12:00 pm GMT Webcast: ow.ly/VRc450XkCuB The presentations will be available for virtual replay for 90 days at ow.ly/qJ3z50XkCuC. Read the news release at investors.compasstherapeutics.com/news-releases/… #CMPX #biotech #biopharmaceutical #therapeutics #immunotherapy

At Compass Therapeutics, our mission is clear: to develop next-generation antibodies into cancer therapies that improve patients’ lives. Our team thrives on collaboration, creativity, and passion — because big goals demand bold science and bold people. Join us — to grow, contribute, and make an impact that matters. -> Explore our current opportunities: ow.ly/TFrs50X4TEV

Join us tomorrow for a fireside chat at: → Morgan Stanley 23rd Annual Global Healthcare Conference New York City Tuesday, Sept. 9, 2025 5:35 p.m. ET Register and view live online at cmpx.info/morganstanley. See the virtual replay for 90 days at cmpx.info/events. #CMPX

Join us Monday as we host a company presentation at: → H.C. Wainwright 27th Annual Global Investment Conference New York City Mon., Sept. 8, 2025 11 am ET Register & view live online at cmpx.info/hcw See the virtual replay for 90 days at cmpx.info/events #CMPX

Join us at the Cantor Global Healthcare Conference in New York City, on Sept. 3 & 4. View our Fireside Chat on Wed., Sept. 3, at 2:10 p.m. ET. Register & view live online cmpx.info/cantor. See the virtual replay for 90 days at cmpx.info/events #CMPX

Join us next Tuesday as we participate in Citi’s 2025 Biopharma Back to School Conference in Boston on Tuesday, Sept. 2, 2025. #CMPX

Compass Therapeutics has announced it will participate in: → Citi’s 2025 Biopharma Back to School Conf. → Cantor Global Healthcare Conf. → H.C. Wainwright 27th Global Investment Conf. → Morgan Stanley 23rd Global Healthcare Conf. Read the news release: bit.ly/3HuecQP